SCHEMBL1858415

SCHEMBL1858415

CCC1(C(=O)O)CCC(=O)CC1.CCOC(=O)[C@@]1(C)CCCCC1=O

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 2/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
F10 P00742 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
OPRM1 P35372 1/20 0.30
MEN1 O00255 1/20 0.30
CYP2D6 P10635 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16391277 0.85 CYP2C19 (0.40) CYP2C19CYP3A4SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL875700 0.85 CYP2C19 (0.40) CYP2C19CYP3A4SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL7722193 0.84 ALDH1A1 (0.39) CYP2C19CYP3A4SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL4812312 0.81 CYP2C19 (0.43) CYP2C19CYP3A4SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL5949812 0.76 POLB (0.41) SMN1; SMN2ALDH1A1TSHRPOLBMAPT
SCHEMBL165219 0.76 CYP2C19 (0.34) CYP2C19CYP2C9MEN1KMT2A
SCHEMBL26013455 0.72 ATM (0.40) CYP2C19CYP3A4SMN1; SMN2F10POLB
SCHEMBL9970859 0.72 ALDH1A1 (0.38) CYP2C19SMN1; SMN2ALDH1A1TSHRMEN1
SCHEMBL6092886 0.71 SMN1; SMN2 (0.42) CYP2C19CYP3A4SMN1; SMN2ALDH1A1CYP2C9
SCHEMBL20390051 0.69 OPRM1 (0.47) CYP2C19CYP3A4ALDH1A1OPRM1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323970-A1 CYCLOHEXYL AMIDE DERIVATIVES AND THEIR USE AS CRF-1 RECEPTOR ANTAGONISTS Novartis AG (CH) 2011-05-25 EP disclosed
WO-2010015655-A1 CYCLOHEXYL AMIDE DERIVATIVES AND THEIR USE AS CRF-1 RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 2010-02-11 WO disclosed